Erosive Esophagitis
NO LONGER ACCEPTING APPLICATIONS
Published on:
September 18, 2024
Sign-up Expiration:
Updated:
Locations:
Salisbury, NC
Dr. Kiran Jagarlamudi
The first phase (Healing Phase) consists of a Screening Period of up to 28 days, a Treatment Period of up to 8 weeks, and a Follow-Up Contact 14 days after the last dose of study drug for patients who do not move to the Maintenance Phase. The second phase (Maintenance Phase) consists of a Treatment Period of 24 weeks and a Follow-Up Contact 14 days after the last dose of study drug.
ENDED